Pubblicazioni

Anti-TIGIT therapies for solid tumors: a systematic review

2023 - ESMO OPEN

Rousseau, A; Parisi, C; Barlesi, F

Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies

2022 - EXPERT OPINION ON PHARMACOTHERAPY

Elia, G.; Ferrari, S. M.; Ragusa, F.; Paparo, S. R.; Mazzi, V.; Ulisse, S.; Benvenga, S.; Antonelli, A.; Fallahi, P.

Race for the Cure: From the Oldest to the Newest Monoclonal Antibodies for Multiple Myeloma Treatment

2022 - BIOMOLECULES

Lapietra, G.; Fazio, F.; Petrucci, M. T.

Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy

2021 - INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY

Dasgeb, Bahar; Leila, Youssefian; Saeidian, Amir Hossein; Kang, Jun; Shi, Wenyin; Shoenberg, Elizabeth; Ertel, Adam; Fortina, Paolo; Vahidnezhad, Hassan; Uitto, Jouni

Immunotherapy in prostate cancer. Recent advances and future directions

2019 - EUROPEAN MEDICAL JOURNAL. UROLOGY

Silvestri, Ida; Tortorella, Elisabetta; Giantulli, Sabrina; Scarpa, Susanna; Sciarra, Alessandro

A perspective of immunotherapy for prostate cancer

2016 - CANCERS

Silvestri, Ida; Cattarino, Susanna; Giantulli, Sabrina; Nazzari, Cristina; Collalti, Giulia; Sciarra, Alessandro